Posts

Exposure to secondhand smoke during chemotherapy makes ...

People who are diagnosed with head and neck cancer often receive a standard type...

Bariatric surgery provides long-term blood glucose cont...

BATON ROUGE – People with type 2 diabetes who underwent bariatric surgery achiev...

Sniffing our way to better health

RIVERSIDE, Calif. — Imagine if we could inhale scents that delay the onset of ca...

Addressing societal concerns of genetic determinism of ...

It has long been known that there is a complex interplay between genetic factors...

The team led by professor Xiaohui Hu from Northwest A&F...

Low temperature stress, as one of the main abiotic stresses, severely hinders pl...

The West is best to spot UFOs

“This [Tic Tac-shaped object that] had just traveled 60 miles in…less than a min...

Long-term survivors of childhood cancer at higher risk ...

New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley...

New study links placental oxygen levels to fetal brain ...

A new study shows oxygenation levels in the placenta, formed during the last thr...

Study details five cutting-edge advances in biomedical ...

Bridging precision engineering and precision medicine to create personalized phy...

Streamlining supply chain operations in focus at Clinic...

The upcoming Clinical Trial Supply Europe 2024 conference will round-up pharma a...

Merck’s Keytruda regimen gains positive EMA CHMP opinion

Merck's KEYTRUDA has received a positive opinion from the EMA CHMP for use in co...

SK bioscience’s typhoid vaccine receives WHO prequalifi...

SK bioscience has achieved a significant milestone with its typhoid conjugate va...

Moderna concludes construction at new mRNA vaccine faci...

Moderna has announced the conclusion of construction works at its new mRNA manuf...

FDA approves Alvotech-Teva’s SIMLANDI jab for multiple ...

The US FDA has granted approval for Alvotech and Teva Pharmaceuticals’ SIMLANDI ...

Bayer wins FDA breakthrough therapy designation for NSC...

Bayer’s oral tyrosine kinase inhibitor is currently in a Phase I trial estimated...

FDA clears PK Med to streamline gout injectable to Phas...

The Phase II prospective, randomised trial will evaluate three doses of PKM-01 t...